scispace - formally typeset
K

Kathleen Kahn

Researcher at University of the Witwatersrand

Publications -  392
Citations -  13597

Kathleen Kahn is an academic researcher from University of the Witwatersrand. The author has contributed to research in topics: Population & Public health. The author has an hindex of 56, co-authored 351 publications receiving 11056 citations. Previous affiliations of Kathleen Kahn include Pasteur Institute & Utrecht University.

Papers
More filters
Journal ArticleDOI

Profile: Agincourt Health and Socio-demographic Surveillance System

TL;DR: Efforts to enhance the research platform include using automated measurement techniques to estimate cause of death by verbal autopsy, full ‘reconciliation’ of in- and out-migrations, follow-up of migrants departing the study area, and optimizing public access to HDSS data are priorities.
Journal ArticleDOI

Research capacity. Enabling the genomic revolution in Africa

Charles N. Rotimi, +245 more
- 20 Jun 2014 - 
TL;DR: If the dearth of genomics research involving Africans persists, the potential health and economic benefits emanating from genomic science may elude an entire continent.
Journal ArticleDOI

The prevalence of stunting, overweight and obesity, and metabolic disease risk in rural South African children

TL;DR: The study highlights that in transitional societies, early stunting and adolescent obesity may co-exist in the same socio-geographic population, but variation in factors such as infectious disease burden and physical activity patterns, as well as social influences, need to be investigated.
Journal ArticleDOI

Validation and application of verbal autopsies in a rural area of South Africa.

TL;DR: To validate the causes of death determined with a single verbal autopsy instrument covering all age groups in the Agincourt subdistrict of rural South Africa.
Journal ArticleDOI

Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study

TL;DR: The dynamics of the mortality transition by comparing the period 2002–05 with 1992–94 are investigated and integrated chronic care based on scaled-up delivery of antiretroviral therapy needed to address this expanding burden is considered.